Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-55...

FDA Drug Recall #D-0511-2017 — Class III — February 17, 2017

Recall Summary

Recall Number D-0511-2017
Classification Class III — Low risk
Date Initiated February 17, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Teva Pharmaceuticals USA
Location North Wales, PA
Product Type Drugs
Quantity 25,916 cartons

Product Description

Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.

Reason for Recall

Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.

Distribution Pattern

Nationwide in the United States and Puerto Rico

Lot / Code Information

Lot # 34025762A, Exp 06/17

Other Recalls from Teva Pharmaceuticals USA

Recall # Classification Product Date
D-0461-2022 Class II Doxylamine Succinate and Pyridoxine Hydrochlori... Jan 18, 2022
D-0520-2022 Class II Tretinoin Capsules, 10 mg, 100 count bottle, Rx... Jan 10, 2022
D-0522-2022 Class III Mimvey (estradiol and norethindrone acetate tab... Jan 7, 2022
D-0521-2022 Class III Mimvey (estradiol and norethindrone acetate tab... Jan 7, 2022
D-0370-2022 Class II MethylPREDNISolone Acetate Injectable Suspensio... Dec 31, 2021

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.